
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Rosalind Watts, Camilla Day, Jacob Krzanowski, et al.
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 5, pp. 520-564
Closed Access | Times Cited: 444
Rosalind Watts, Camilla Day, Jacob Krzanowski, et al.
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 5, pp. 520-564
Closed Access | Times Cited: 444
Showing 1-25 of 444 citing articles:
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Robin Carhart‐Harris, Mark Bolstridge, Camilla Day, et al.
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 399-408
Open Access | Times Cited: 761
Robin Carhart‐Harris, Mark Bolstridge, Camilla Day, et al.
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 399-408
Open Access | Times Cited: 761
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin Carhart‐Harris, Leor Roseman, Mark Bolstridge, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 464
Robin Carhart‐Harris, Leor Roseman, Mark Bolstridge, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 464
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 432
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 432
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
Increased global integration in the brain after psilocybin therapy for depression
Richard E. Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 844-851
Open Access | Times Cited: 303
Richard E. Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 844-851
Open Access | Times Cited: 303
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
Tehseen Noorani, Albert Garcia‐Romeu, Thomas Cody Swift, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 756-769
Closed Access | Times Cited: 228
Tehseen Noorani, Albert Garcia‐Romeu, Thomas Cody Swift, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 756-769
Closed Access | Times Cited: 228
Effects of psilocybin therapy on personality structure
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 223
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 223
The hidden therapist: evidence for a central role of music in psychedelic therapy
Mendel Kaelen, Bruna Giribaldi, Jordan Raine, et al.
Psychopharmacology (2018) Vol. 235, Iss. 2, pp. 505-519
Open Access | Times Cited: 199
Mendel Kaelen, Bruna Giribaldi, Jordan Raine, et al.
Psychopharmacology (2018) Vol. 235, Iss. 2, pp. 505-519
Open Access | Times Cited: 199
The use of the psychological flexibility model to support psychedelic assisted therapy
Rosalind Watts, Jason B. Luoma
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 92-102
Closed Access | Times Cited: 189
Rosalind Watts, Jason B. Luoma
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 92-102
Closed Access | Times Cited: 189
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 187
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 187
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 183
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 183
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 181
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 181
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Leor Roseman, Lysia Demetriou, Matthew B. Wall, et al.
Neuropharmacology (2017) Vol. 142, pp. 263-269
Open Access | Times Cited: 179
Leor Roseman, Lysia Demetriou, Matthew B. Wall, et al.
Neuropharmacology (2017) Vol. 142, pp. 263-269
Open Access | Times Cited: 179
The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
Ido Hartogsohn
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 177
Ido Hartogsohn
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 177
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
Unifying Theories of Psychedelic Drug Effects
Link Ray Swanson
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 165
Link Ray Swanson
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 165
A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, et al.
European Neuropsychopharmacology (2020) Vol. 33, pp. 71-80
Open Access | Times Cited: 154
M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, et al.
European Neuropsychopharmacology (2020) Vol. 33, pp. 71-80
Open Access | Times Cited: 154
The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 153
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 153
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Lea J. Mertens, Matthew B. Wall, Leor Roseman, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 167-180
Closed Access | Times Cited: 152
Lea J. Mertens, Matthew B. Wall, Leor Roseman, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 167-180
Closed Access | Times Cited: 152